4.6 Article

Feasibility of Transcatheter Aortic Valve Implantation Without Balloon Pre-Dilation A Pilot Study

Journal

JACC-CARDIOVASCULAR INTERVENTIONS
Volume 4, Issue 7, Pages 751-757

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcin.2011.03.015

Keywords

aortic valve stenosis; balloon pre-dilation; transcatheter aortic valve implantation

Ask authors/readers for more resources

Objectives The purpose of this pilot study was to evaluate the feasibility and safety of transcatheter aortic valve implantation (TAVI) without balloon pre-dilation. Background Balloon pre-dilation of the stenosed aortic valve is currently believed to be a necessary step for valve preparation before device placement in patients undergoing TAVI and, therefore, is considered an obligatory part of the procedure. However, clear evidence supporting this policy is lacking. In contrast, pre-dilation might be responsible in part for distal embolizations as well as atrioventricular conduction disturbances seen during TAVI procedures. Methods A total of 60 consecutive patients (mean age 80.1 +/- 6.4 years, 53% female, mean logistic Euro Score 23.3 +/- 15.2%) undergoing TAVI using the self-expanding Medtronic Core Valve prosthesis (Medtronic, Minneapolis, Minnesota) have been prospectively enrolled at 13 international centers. Results Pre-procedural mean transaortic valve gradient was 47.8 +/- 15.5 mm Hg, mean effective orifice area was 0.67 +/- 0.15 cm(2). Technical success rate was 96.7% (58 of 60) of patients. Post-dilation was performed in 16.7% (10 of 60) of patients. Post-procedural mean valve gradient was 4.4 +/- 2.0 mm Hg. Circular and noncircular valve configuration was present in 41 and 19 cases (68.3% vs. 31.7%), respectively, with similar effective orifice areas (1.74 +/- 0.10 cm(2) vs. 1.71 +/- 0.22 cm(2), p = NS). In-hospital mortality, myocardial infarction, stroke, and major vascular complications occurred in 6.7% (4 of 60), 0%, 5%, and 10% of patients. There was no valve embolization. New permanent pacing was needed in 11.7% (7 of 60) of patients. Conclusions Transcatheter aortic valve implantation without balloon pre-dilation is feasible and safe, resulting in similar acute safety and efficacy as the current standard approach of TAVI with pre-dilation. (J Am Coll Cardiol Intv 2011;4:751-7) (C) 2011 by the American College of Cardiology Foundation

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available